230 related articles for article (PubMed ID: 32009905)
1. Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.
Fernández-Nogales M; Lucas JJ
Front Cell Neurosci; 2019; 13():574. PubMed ID: 32009905
[TBL] [Abstract][Full Text] [Related]
2. Faulty splicing and cytoskeleton abnormalities in Huntington's disease.
Fernández-Nogales M; Santos-Galindo M; Hernández IH; Cabrera JR; Lucas JJ
Brain Pathol; 2016 Nov; 26(6):772-778. PubMed ID: 27529534
[TBL] [Abstract][Full Text] [Related]
3. Tau-positive nuclear indentations in P301S tauopathy mice.
Fernández-Nogales M; Santos-Galindo M; Merchán-Rubira J; Hoozemans JJM; Rábano A; Ferrer I; Avila J; Hernández F; Lucas JJ
Brain Pathol; 2017 May; 27(3):314-322. PubMed ID: 27338164
[TBL] [Abstract][Full Text] [Related]
4. Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington's Disease Brain.
Petry S; Nateghi B; Keraudren R; Sergeant N; Planel E; Hébert SS; St-Amour I
Neuroscience; 2023 May; 518():54-63. PubMed ID: 35868517
[TBL] [Abstract][Full Text] [Related]
5. Huntington's disease is a four-repeat tauopathy with tau nuclear rods.
Fernández-Nogales M; Cabrera JR; Santos-Galindo M; Hoozemans JJ; Ferrer I; Rozemuller AJ; Hernández F; Avila J; Lucas JJ
Nat Med; 2014 Aug; 20(8):881-5. PubMed ID: 25038828
[TBL] [Abstract][Full Text] [Related]
6. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.
Moussavi Nik SH; Newman M; Ganesan S; Chen M; Martins R; Verdile G; Lardelli M
BMC Res Notes; 2014 Oct; 7():767. PubMed ID: 25359609
[TBL] [Abstract][Full Text] [Related]
8. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
9. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.
Gratuze M; Noël A; Julien C; Cisbani G; Milot-Rousseau P; Morin F; Dickler M; Goupil C; Bezeau F; Poitras I; Bissonnette S; Whittington RA; Hébert SS; Cicchetti F; Parker JA; Samadi P; Planel E
Hum Mol Genet; 2015 Jan; 24(1):86-99. PubMed ID: 25205109
[TBL] [Abstract][Full Text] [Related]
10. Targeting Tau to Treat Clinical Features of Huntington's Disease.
Masnata M; Salem S; de Rus Jacquet A; Anwer M; Cicchetti F
Front Neurol; 2020; 11():580732. PubMed ID: 33329322
[TBL] [Abstract][Full Text] [Related]
11. Untangling the Role of Tau in Huntington's Disease Pathology.
Salem S; Cicchetti F
J Huntingtons Dis; 2023; 12(1):15-29. PubMed ID: 36806513
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.
Espíndola SL; Damianich A; Alvarez RJ; Sartor M; Belforte JE; Ferrario JE; Gallo JM; Avale ME
Cell Rep; 2018 Apr; 23(3):709-715. PubMed ID: 29669277
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent increase in tau phosphorylation at serine 396 in Huntington's disease pre-frontal cortex.
Petrozziello T; Huntress SS; Castillo-Torres AL; Quinn JP; Connors TR; Auger CA; Mills AN; Kim SE; Liu S; Mahmood F; Boudi A; Wu M; Sapp E; Kivisäkk P; Sunderesh SR; Pouladi MA; Arnold SE; Hyman BT; Rosas HD; DiFiglia M; Pinto RM; Kegel-Gleason K; Sadri-Vakili G
medRxiv; 2023 Jun; ():. PubMed ID: 37333415
[TBL] [Abstract][Full Text] [Related]
15. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
16. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Jung HJ; Park SS; Mok JO; Lee TK; Park CS; Park SA
Exp Neurol; 2011 Apr; 228(2):232-41. PubMed ID: 21281635
[TBL] [Abstract][Full Text] [Related]
18. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
19. A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients.
Liu P; Smith BR; Huang ES; Mahesh A; Vonsattel JPG; Petersen AJ; Gomez-Pastor R; Ashe KH
Acta Neuropathol Commun; 2019 Jul; 7(1):111. PubMed ID: 31358058
[TBL] [Abstract][Full Text] [Related]
20. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
